chr9-120913647-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_005658.5(TRAF1):c.386G>A(p.Arg129Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,613,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_005658.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRAF1 | NM_005658.5 | c.386G>A | p.Arg129Gln | missense_variant | 5/8 | ENST00000373887.8 | |
TRAF1 | NM_001190945.2 | c.386G>A | p.Arg129Gln | missense_variant | 6/9 | ||
TRAF1 | NM_001190947.2 | c.20G>A | p.Arg7Gln | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRAF1 | ENST00000373887.8 | c.386G>A | p.Arg129Gln | missense_variant | 5/8 | 1 | NM_005658.5 | P1 | |
TRAF1 | ENST00000540010.1 | c.386G>A | p.Arg129Gln | missense_variant | 6/9 | 1 | P1 | ||
TRAF1 | ENST00000546084.5 | c.20G>A | p.Arg7Gln | missense_variant | 3/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249870Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135426
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461252Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 726858
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74368
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at